Differentiation of Rodent Immune and Hematopoietic System Reactive Lesions from Neoplasias

Toxicologic Pathology

Volumn 40, Issue 3, 2012, Pages 425-434

  Ward, Jerrold M ^a   Rehg, Jerold E ^b   Morse, Herbert C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

clonality; hematopoietic system; immune system; immunohistochemistry; lymph nodes; lymphoid; lymphoid hyperplasia; lymphoma; lymphoproliferative disease; mice; rats; spleen; Thymus

Indexed keywords

CLONAL VARIATION; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; LYMPH NODE; LYMPHADENOPATHY; LYMPHATIC SYSTEM TUMOR; LYMPHOID HYPERPLASIA; LYMPHOID TISSUE; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SPLEEN; SPLEEN INJURY; THYMUS DISEASE; TUMOR DIFFERENTIATION; ANIMAL; HEMATOPOIETIC SYSTEM; HYPERPLASIA; IMMUNOLOGY; MOUSE; PATHOLOGY; RAT; REVIEW;

ANIMALS; HEMATOPOIETIC SYSTEM; HUMANS; HYPERPLASIA; LYMPHOID TISSUE; LYMPHOPROLIFERATIVE DISORDERS; MICE; RATS;

EID: 84867472602     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311431467     Document Type: Article

References (62)

1. Adams J. M. Harris A. W. Pinkert C. A. Corcoran L. M. Alexander W. S. Cory S. Palmiter R. D. Brinster R. L. (1985). The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533–38.
2. Barton E. Mandal P. Speck S. H. (2011). Pathogenesis and host control of gammaherpesviruses: Lessons from the mouse. Ann Rev Immunology 29, 351–97.
3. Cattoretti G. Pasqualucci L. Ballon G. Tam W. Nandula S. V. Shen Q. Mo T. Murty V. V. Dalla-Favera R. (2005). Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 7, 445–55.
4. Cesta M. F. (2006). Normal structure, function, and histology of the spleen. Toxicol Pathol 34, 455–65.
5. Choi C. W. Chung Y. J. Slape C. Aplan P. D. (2009). A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement. J Immunol 183, 6227–35.
6. Cohen P. L. Eisenberg R. A. (1991). Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunology 9, 243–69.
7. Davidson W. F. Giese T. Fredrickson T. N. (1998). Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J Exp Med 187, 1825–38.
8. Dunn T. B. (1954). Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer I 14, 1281–433.
9. Dunnick J. K. Hardisty J. F. Herbert R. A. Seely J. C. Furedi-Machacek E. M. Foley J. F. Lacks G. D. Stasiewicz S. French J. E. (1997). Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice. Toxicol Pathol 25, 533–40.
10. Elmore S. A. (2006a). Histopathology of the lymph nodes. Toxicol Pathol 34, 425–54.
11. Elmore S. A. (2006b). Enhanced histopathology of the thymus. Toxicol Pathol 34 656–65.
12. Elmore S. A. (2006c). Enhanced histopathology of the lymph nodes. Toxicol Pathol 34, 634–47.
13. Elmore S. A. (2006d). Enhanced histopathology of the spleen. Toxicol Pathol 34, 648–55.
14. Elmore S. A. (2010). Enhanced histopathology evaluation of lymphoid organs. Method Mol Biol 598, 323–39.
15. Elmore S. A. (in press). Enhanced histopathology of the immune system. Toxicol Pathol.
16. Fredrickson T. N. Tang Y. Chattopadhyay S. K. Morse H. C. III Hartley J. W. (1993). Retrovirus-induced lymphoproliferation as a model for developing diagnostic criteria for malignant lymphoma in mice. Toxicol Pathol 21, 219–28.
17. Germolec D. R. Kashon M. Nyska A. Kuper C. F. Portier C. Kommineni C. Johnson K. A. Luster M. I. (2004). The accuracy of extended histopathology to detect immunotoxic chemicals. Toxicol Sci: 82, 504–14.
18. Germolec D. R. Nyska A. Kashon M. Kuper C. F. Portier C. Kommineni C. Johnson K. A. Luster M. I. (2004). Extended histopathology in immunotoxicity testing: Interlaboratory validation studies. Toxicol Sci 78, 107–15.
19. Haley P. Perry R. Ennulat D. Frame S. Johnson C. Lapointe J. M. Nyska A. Snyder P. Walker D. Walter G. (2005). STP position paper: Best practice guideline for the routine pathology evaluation of the immune system. Toxicol Path 33, 404–7.
20. Hao X. Fredrickson T. N. Chattopadhyay S. K. Han W. Qi C. F. Wang Z. Ward J. M. Hartley J. W. Morse H. C. III. (2010). The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. Vet Pathol 47, 434–45.
21. Hartley J. W. Chattopadhyay S. K. Lander M. R. Taddesse-Heath L. Naghashfar Z. Morse H. C. III Fredrickson T. N. (2000). Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses. Lab Invest 80, 159–69.
22. Hartley J. W. Fredrickson T. N. Yetter R. A. Makino M. Morse H. C. III. (1989). Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol 63, 1223–31.
23. Jaffe E. S. Vardiman J. Campo E. Arber D. Harris N. L. (2011). Hematopathology. p. 1072, Saunders, St. Louis, MO.
24. Karupiah G. Sacks T. E. Klinman D. M. Fredrickson T. N. Hartley J. W. Chen J. H. Morse H. C. III. (1998). Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40. Virology 240, 12–26.
25. Klinken S. P. Fredrickson T. N. Hartley J. W. Yetter R. A. Morse H. C., III. (1988). Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J Immunol 140, 1123–31.
26. Kogan S. C. Ward J. M. Anver M. R. Berman J. J. Brayton C. Cardiff R. D. Carter J. S. de Coronado S. Downing J. R. Fredrickson T. N. Haines D. C. Harris A. W. Harris N. L. Hiai H. Jaffe E. S. MacLennan I. C. Pandolfi P. P. Pattengale P. K. Perkins A. S. Simpson R. M. Tuttle M. S. Wong J. F. Morse H. C., III. (2002). Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100, 238–45.
27. Konishi N. Ward J. M. Reynolds C. W. Lijinsky W. (1988). Thymic T-cell lymphoma with the CD8+ (OX-8), CD4+ (W3/25) phenotype, induced in F344/NCr rats by nitroso-2-hydroxypropylurea. Thymus 12, 225–37.
28. Kovalchuk A. L. Kim J. S. Park S. S. Coleman A. E. Ward J. M. Morse H. C. III Kishimoto T. Potter M. Janz S. (2002). IL-6 transgenic mouse model for extraosseous plasmacytoma. Proc Natl Acad Sci U S A 99, 1509–14.
29. Kunder S. Calzada-Wack J. Holzlwimmer G. Muller J. Kloss C. Howat W. Schmidt J. Hofler H. Warren M. Quintanilla-Martinez L. (2007). A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: Analysis of mouse specific and human antibodies cross-reactive with murine tissue. Toxicol Pathol 35, 366–75.
30. Kuper C. F. Harleman J. H. Richter-Reichelm H. B. Vos J. G. (2000). Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicol Pathol 28, 454–66.
31. Li Z. Wang H. Xue L. Shin D. M. Roopenian D. Xu W. Qi C. F. Sangster M. Y. Orihuela C. J. Tuomanen E. Rehg J. E. Cui X. Zhang Q. Morse H. C. III Morris S. W. (2009). Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. Blood 114, 4158–68.
32. Linden M. Ward J. M. Cherian S. (in press). Hematopoietic and Lymphoid Tissues. In Comparative Anatomy and Histology: A Mouse and Human Atlas (Treuting P. M. Dintzis S. M., eds.), Elsevier, Amsterdam, The Netherlands.
33. Long R. E. Knutsen G. Robinson M. (1986). Myeloid hyperplasia in the SENCAR mouse: Differentiation from granulocytic leukemia. Environ Health Persp 68, 117–23.
34. Mebius R. E. Kraal G. (2005). Structure and function of the spleen. Nature Rev Immunol 5, 606–16.
35. Mikaelian I. Nanney L. B. Parman K. S. Kusewitt D. F. Ward J. M. Naf D. Krupke D. M. Eppig J. T. Bult C. J. Seymour R. Ichiki T. Sundberg J. P. (2004). Antibodies that label paraffin-embedded mouse tissues: A collaborative endeavor. Toxicol Pathol 32, 181–91.
36. Morse H. C. Anver M. R. Fredrickson T. N. Haines D. C. Harris A. W. Harris N. L. Jaffe E. S. Kogan S. C. MacLennan I. C. Pattengale P. K. Ward J. M. (2002). Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100, 246–58.
37. Morse H. C. III Qi C. F. Chattopadhyay S. K. Hori M. Taddesse-Heath L. Ozato K. Hartley J. W. Taylor B. A. Ward J. M. Jenkins N. A. Copeland N. G. Fredrickson T. N. (2001). Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leukemia Res 25, 719–33.
38. Ohtani O. Ohtani Y. (2008). Structure and function of rat lymph nodes. Arch Histol Cytol 71, 69–76.
39. Park S. S. Kim J. S. Tessarollo L. Owens J. D. Peng L. Han S. S. Tae Chung S. Torrey T. A. Cheung W. C. Polakiewicz R. D. McNeil N. Ried T. Mushinski J. F. Morse H. C. III, Janz S. (2005). Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res 65, 1306–15.
40. Pearse G. (2006a). Normal structure, function and histology of the thymus. Toxicol Pathol 34, 504–14.
41. Pearse G. (2006b). Histopathology of the thymus. Toxicol Pathol 34, 515–47.
42. Pearse G. Pietersma A. Cunliffe J. Foster J. R. Turton J. Derbyshire N. Randall K. J. (2009). Time-course study of the immunotoxic effects of the anticancer drug chlorambucil in the rat. Toxicol Pathol 37, 887–901.
43. Qi C. F. Shin D. M. Li Z. Wang H. Feng J. Hartley J. W. Fredrickson T. N. Kovalchuk A. L. Morse H. C. (2010). III. Anaplastic plasmacytomas: Relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice. J Pathol 221, 106–16.
44. Rehg J. E. Bush D. Ward J. M. (in press). The utility of IHC in the identification of lymphohematopoietic cells in normal tissues, and interpretation of proliferative, inflammatory and toxic lesions. Toxicol Pathol.
45. Rehg J. E. Sundberg J. P. (2008). Utility of antiPax5 in the diagnosis of lymphoproliferative disorders and neoplasia in mice. Comp Med 58, 246–52.
46. Schmidtko J. Wang R. Wu C. L. Mauiyyedi S. Harris N. L. Della Pelle P. Brousaides N. Zagachin L. Ferry J. A. Wang F. Kawai T. Sachs D. H. Cosimi B. A. Colvin R. B. (2002). Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation 73, 1431–39.
47. Suttie A. W. (2006). Histopathology of the spleen. Toxicol Pathol 34, 466–503.
48. Swerdlow S. H. Campo E. Harris N. L. Jaffe E. S. Pileri S. A. Stein H. Thiele J. Vardiman J. W. (2008). WHO classification of tumours of haematopoietic and lymphoid tissues. p. 439. International Agency for Research on Cancer, Lyon, France.
49. Tang J. C. Ho F. C. Chan A. C. Chow E. Y. Srivastava G. (1998) Progression of spontaneous lymphomas in SJL mice: Monitoring in vivo clonal evolution with molecular markers in sequential splenic samples. Lab Invest 78, 1459–66.
50. Travlos G. S. (2006). Histopathology of bone marrow. Toxicol Pathol 34, 566–98.
51. Van den Broeck W. Derore A. Simoens P. (2006). Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 312, 12–19.
52. Waisberg M. Tarasenko T. Vickers B. K. Scott B. L. Willcocks L. C. Molina-Cruz A. Pierce M. A. Huang C. Y. Torres-Velez F. J. Smith K. G. Barillas-Mury C. Miller L. H. Pierce S. K. Bolland S. (2011). Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc Natl Acad Sci U S A 108, 1122–27.
53. Ward J. M. (1990a). Classification of reactive lesions of lymph nodes. In Hemopoetic System (Jones T. C. Ward J. M. Mohr U. Hunt R. D., eds.), pp. 155–161. Springer-Verlag, Berlin, Germany.
54. Ward J. M. (1990b). Classification of reactive lesions, spleen. In Hemopoetic System (Jones T. C. Ward J. M. Mohr U. Hunt R. D., eds.), pp. 220–26. Springer-Verlag, Berlin, Germany.
55. Ward J. M. (1990c). Early follicular center cell lymphoma, mouse. In Hemopoetic System (Jones T. C. Ward J. M. Mohr U. Hunt R.D., eds.), pp. 212–16. Springer-Verlag, Berlin, Germany.
56. Ward J. M. Mann P. C. Morishima H. Frith C. H. (1999). Thymus, spleen and lymph nodes. In Pathology of the Mouse (Maronpot R. R., ed.), pp. 333–60. Cache River Press, Vienna, IL.
57. Ward J. M. (2006). Lymphomas and leukemias in mice. Exp Toxicol Pathol 57, 377–81.
58. Ward J. M. Erexson C. R. Faucette L. J. Foley J. F. Dijkstra C. Cattoretti G. (2006). Immunohistochemical markers for the rodent immune system. Toxicol Pathol 34, 616–30.
59. Ward J. M. Tadesse-Heath L. Perkins S. N. Chattopadhyay S. K. Hursting S. D. Morse H. C. 3rd (1999). Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice. Lab Invest 79, 3–14.
60. Ward J. M. Uno H. Frith C. H. (1993). Immunohistochemistry and morphology of reactive lesions in lymph nodes and spleen from rats and mice. Toxicol Pathol 21, 199–205.
61. Willard-Mack C. L. (2006). Normal structure, function, and histology of lymph nodes. Toxicol Pathol 34, 409–24.
62. Xiang H. Noonan E. J. Wang J. Duan H. Ma L. Michie S. Boxer L. M. (2011). The immunoglobulin heavy chain gene 3′ enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells. Leukemia 25, 1484–93.